Login / Signup

CRISPR editing as a therapeutic strategy for Duchenne muscular dystrophy-anti-Cas9 immune response casts its shadow over safety and efficacy.

James E Dowling
Published in: Gene therapy (2022)
Keyphrases
  • crispr cas
  • duchenne muscular dystrophy
  • genome editing
  • immune response
  • muscular dystrophy
  • dendritic cells